Mark D. Fladrich
Member of the Corporate Executive Board & Chief Co
administration
Grunenthal
Germany
Biography
Mr. Mark Donald Fladrich has been Chief Commercial Officer and Member of The Corporate Executive Board at Grünenthal GmbH since September 1, 2017. Mr. Fladrich has almost 30 years of experience in the pharmaceutical industry. Mr. Fladrich served as Vice President of Southern & Western Europe at AstraZeneca GmbH. Mr. Fladrich served as the Managing Director of AstraZeneca Deutschland at AstraZeneca GmbH. He served as Managing Director and Managing Director of Newzeland at AstraZeneca Pty Limited from October 2011 to May 2015. He was also globally responsible for all phase III products and promoted brands and for providing commercial input into R&D for all stages of clinical development. He served as a Director at AstraZeneca Limited until May 31, 2015. He served as a Director at AstraZeneca Pty Limited since September 6, 2011 until July 29, 2015.
Research Interest
business
